CEACAM5 and cancer: Furthermore, changes in hematological markers were observed through a complete blood count, liver function test, kidney function test, C-reactive protein, cancer markers such as carcinoembryonic antigen, D-dimer, ferritin, and lactate dehydrogenase, glycemic indices such as glycosylated hemoglobin, and vitamin D levels.